视网膜静脉阻塞被引量：10

Retinal vein occlusion

下载PDF

导出

摘要视网膜静脉阻塞是老年人常见的眼底血管病,有典型的眼底表现,诊断一般不难。但因其病因未能完全确定,治疗还缺乏有效措施。目前的治疗主要是针对视力下降,甚或破坏眼球的并发症,如黄斑水肿及新生血管。针对国内尤其边缘地区眼科医师对本病治疗还缺乏统一的认识,本文结合文献,尤其是参考具有循证医学价值的文献以及我们的临床经验,对本病的临床诊治方法作一介绍。 Retinal vein occlusion （RVO） is a common vascular disorder in elderly. From its typical fundus mani festations, diagnosis is usually not difficult. Efficient treatment is still lacking, since its exact etiology is unclear. The current treatment is mainly aimed at its visual threatening or globe destructive complications, such as macular edema and neovascularization caused by RVO. Universal management guidelines are not practiced in China especially in remote area. This article is intended to recommend guidelines for diagnosing and managing RVO by reviewing hteratures, especially those with evidence based articles, and with our own experiences.

作者王文吉

机构地区复旦大学附属眼耳鼻喉科医院眼科

出处《中国眼耳鼻喉科杂志》 2012年第2期78-81,共4页 Chinese Journal of Ophthalmology and Otorhinolaryngology

关键词视网膜静脉阻塞缺血型视网膜静脉阻塞非缺血型黄斑水肿新生血管激光光凝抗新生血管抗体 Retinal vein occlusion, ischemic type Retinal vein occlusion, non-ischemic type Macular edema Neovascularization Laser photocoagulation Anti-neovascularization antibody

分类号 R774.1 [医药卫生—眼科]

引文网络
相关文献

参考文献18

1Noma H, Funatsu H, Mimura T, et al. Increase of vascular endothelial group factor and interleukin-6 in the aqueous humour of patients with macular edema and central retinal vein occlusion [ J ]. Acta Ophthalmol,2010,88 (6) :646-651.
2Fong AC, Schatz H. Central retinal vein occlusion in young adults [ J ]. Surv Ophthalmol, 1993,38 ( 1 ) :88.
3Hoeh AE, Ach T,Schaal KB, et al. Long-term follow-up of OCT-guided bevacizumab treatment of macular edema due to retinal vein occlusion [ J ]. Graefes Arch Clin Exp Ophthalmol, 2009, 247 (12): 1635-1641.
4Weiss JN. Treatment of central retinal vein occlusion by injection of tissue plasminogen activator into a retinal vein [ J ]. Am J Ophthalmol,1998,126( 1 ) :142-144.
5Bynoe LA, Weiss JN. Retinal endovascular surgery and intravitreal triamcinolone acetonide for central vein occlusion in young adults [ J]. Am J Ophthalmol,2003,135 ( 3 ) : 382-384.
6Ehlers JP, Decroos FC, Fekrat S. Intravitreal bevacizumab for macular edema secondary to branch retinal vein occlusion [ J ]. Retina, 2011,31 (9) :1856-1862.
7Figueroa MS, Contreras I, Noval S, et al. Results of bevacizumab as the primary treatment for retinal vein occlusions [ J ]. Br J Ophthalmol,2010,94 ( 8 ) : 1052-1056.
8Campochiaro PA, Heier JS, Feiner L, et al. Ranibizumab for macular edema following branch retinal vein occlusion : six-month primary end point results of a phase III study[ J ]. Ophthalmology,2010,117 (6) : 1102-1112.
9Park CH, Jaffe GJ, Fekrat S. Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion [ J ]. Am J Ophthalmol,2003,136 ( 3 ) :419-425.
10The Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) Study Report 5. A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion[J]. Arch Ophthalrnol,2009,127(9) :1101- 1114.